Sarcoma  >>  Ogsiveo (nirogacestat)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ogsiveo (nirogacestat) / SpringWorks Therap
DeFi, NCT03785964 / 2018-001991-39: Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Checkmark Data from DeFi trial for Desmoid Tumors
May 2022 - May 2022: Data from DeFi trial for Desmoid Tumors
Active, not recruiting
3
142
Europe, Canada, US
Nirogacestat oral tablet, PF-03084014, Placebo Oral Tablet
SpringWorks Therapeutics, Inc.
Desmoid Tumor, Aggressive Fibromatosis
04/22
12/24

Download Options